Scarica l'app Stockscreener
58.64
2.36%
-1.42
Dopo l'orario di chiusura:
60.00
1.36
+2.32%
Precedente Chiudi:
$60.06
Aprire:
$59.87
Volume 24 ore:
1.14M
Relative Volume:
1.24
Capitalizzazione di mercato:
$3.24B
Reddito:
$249.12M
Utile/perdita netta:
$-90.19M
Rapporto P/E:
-34.49
EPS:
-1.7
Flusso di cassa netto:
$-88.21M
1 W Prestazione:
-0.49%
1M Prestazione:
-0.49%
6M Prestazione:
-20.17%
1 anno Prestazione:
-13.06%
Intervallo 1D:
$57.90
$60.57
Intervallo di 1 settimana:
$55.76
$62.17
Portata 52W:
$47.04
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Nome
Procept Biorobotics Corp
Settore
Industria
Telefono
(650) 232-9832
Indirizzo
150 BAYTECH DRIVE, SAN JOSE
Confronta PRCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
58.64 | 3.32B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Iniziato | Stephens | Overweight |
| 2025-07-07 | Iniziato | Oppenheimer | Perform |
| 2024-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Iniziato | Jefferies | Hold |
| 2023-08-11 | Iniziato | Piper Sandler | Overweight |
| 2023-05-31 | Iniziato | William Blair | Outperform |
| 2022-10-31 | Iniziato | BTIG Research | Neutral |
| 2022-10-25 | Iniziato | Truist | Buy |
| 2022-09-02 | Iniziato | Wells Fargo | Overweight |
| 2022-07-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-10-11 | Iniziato | BofA Securities | Buy |
| 2021-10-11 | Iniziato | Cowen | Outperform |
| 2021-10-11 | Iniziato | Goldman | Neutral |
| 2021-10-11 | Iniziato | Guggenheim | Buy |
| 2021-10-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Procept Biorobotics Corp Borsa (PRCT) Ultime notizie
PROCEPT BioRobotics: Promising Growth Under New Leadership and Attractive Valuation - TipRanks
Larry Wood to join PROCEPT BioRobotics as CEO, company reports 48% revenue growth - Investing.com
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to - GlobeNewswire
PROCEPT BioRobotics Achieves 48% Revenue Surge to $79.2M as Edwards Lifesciences Veteran Takes CEO Role - Stock Titan
What analysts say about PROCEPT BioRobotics Corporation stockRapid wealth accumulation - Autocar Professional
Is PROCEPT BioRobotics Corporation stock a growth or value playFree Trend-Following Techniques - jammulinksnews.com
What drives PROCEPT BioRobotics Corporation stock priceRapid-fire capital growth - jammulinksnews.com
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy - GlobeNewswire
Redefining Prostate Cancer Care: How PROCEPT BioRobotics' Aquablation Therapy Could Disrupt Urology and Unlock a $10B+ Market - AInvest
PROCEPT BioRobotics Corporation Stock Analysis and ForecastBreakthrough stock performance - jammulinksnews.com
Is PROCEPT BioRobotics Corporation a good long term investmentMassive portfolio appreciation - jammulinksnews.com
Evaluating PROCEPT BioRobotics (PRCT) Ahead of Q2 2025 Earnings: A Strategic Buy Opportunity in Surgical Robotics? - AInvest
Procept Biorobotics shares rise 1.65% after-hours after announcing Q2 2025 earnings report date. - AInvest
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times
PROCEPT BioRobotics to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Quiver Quantitative
PROCEPT BioRobotics Corp (PRCT) stock falls 3.23% on July 21 - AInvest
PROCEPT BioRobotics Corp Shares Surge 3.68% Amid Analyst Predictions of 26.35% Upside - AInvest
Nisa Investment Advisors LLC Purchases 270 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World
Why PROCEPT BioRobotics Corporation stock is on top investor watchlistsExpert Trading Flow - Newser
how procept biorobotics corporation stock performs during market volatilityGroup Only Stock Signals - Newser
Morgan Stanley Lowers PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $68.00 - Defense World
Q2 EPS Estimate for PROCEPT BioRobotics Raised by Analyst - Defense World
Positive Outlook on PROCEPT BioRobotics Amid New Fee Schedule Developments for Aquablation - AInvest
Procept BioRobotics Receives Favorable CMS Updates and Reimbursement Stability - AInvest
Procept BioRobotics says Aquablation therapy assigned a Category I code - MSN
A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $68 to $85 - 富途牛牛
Teacher Retirement System of Texas Has $646,000 Stock Holdings in PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 4.7% Following Analyst Downgrade - Defense World
How PROCEPT BioRobotics Corporation stock performs during market volatilityFree Smart Money Stock Analysis - Newser
Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionPredictable Return Stock Picks - Newser
What makes PROCEPT BioRobotics Corporation stock price move sharplyFree Real-Time Trading Opportunities - Newser
Procept BioRobotics Awarded Category 1 Code in 2026 Medicare Proposal - MarketScreener
Procept BioRobotics stock maintains Buy rating at BofA despite Medicare cuts By Investing.com - Investing.com South Africa
Procept BioRobotics stock maintains Buy rating at BofA despite Medicare cuts - Investing.com Nigeria
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule - Stock Titan
Buy Recommendation for Procept BioRobotics Supported by Favorable CMS Updates and Reimbursement Stability - TipRanks
Procept Biorobotics Corp Azioni (PRCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.03%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):